Which of the following best describes the purpose of the ICER framework?

The ICER framework, which stands for the Institute for Clinical and Economic Review, is designed to evaluate the economic value of medical interventions, including genetic interventions. Its purpose is to provide a systematic approach to assess the cost-effectiveness and overall value of treatments in comparison to their health outcomes. By analyzing how much health benefit is gained per dollar spent, the framework informs stakeholders—including healthcare providers, policymakers, and patients—about the financial implications of introducing genetic interventions in clinical settings. This evaluation is essential for making informed decisions about healthcare resource allocation, especially in genetics, where the costs can be significant and the benefits can vary widely among different populations and interventions.

In contrast, evaluating genetic disorders focuses strictly on the clinical aspects of those disorders without considering the comprehensive economic impact of interventions. Measuring the efficacy of public health policies may involve broad assessments of various health factors and does not specifically target genetic interventions. Developing new genetic testing methodologies is a crucial aspect of advancing genetic care, yet it does not address the economic implications or value assessments that the ICER framework emphasizes.